Ara
Toplam kayıt 225, listelenen: 51-60
Use of Eculizumab in Pediatric Patients with Late Antibody-Mediated Rejection After Kidney Transplantation
(2022)
Late antibody-mediated rejection triggered by donor-specific antibodies is a leading cause of kidney allograft failure. Effective treatment options for late antibody-mediated rejection are limited in renal transplant ...
Liver Transplant Recipients Who Survive for More Than 10 Years: A Long-Term Survey
(2022)
Objectives: Liver transplant is the gold standard treatment for end-stage liver failure. Short-term and midterm surveys have been published, but there are few long-term surveys. Here, we report the outcomes of our long-term ...